Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1987 Sep;25(9):1735–1740. doi: 10.1128/jcm.25.9.1735-1740.1987

Induction and measurement of 2',5'-oligoadenylate synthetase in Madin-Darby bovine kidney cells and in cattle.

E C Short Jr 1, R W Fulton 1
PMCID: PMC269318  PMID: 2443533

Abstract

2',5'-Oligoadenylate [2',5'-oligo(A)] was separated from 14C-labeled nucleosides produced in the 2',5'-oligo(A) synthetase assay by using 100-microliters columns of Dowex 1. No detectable nucleoside remained on the column after elution with 20 column volumes of water, whereas less than 1% of oligonucleotides were eluted from the column. At least 99% of oligonucleotides were eluted from the column with 1 M NaCl, pH 2. The major product had properties consistent with 2',5'-oligo(A). Exposure to alpha-1 bovine interferon (IFN) caused an increase in cellular 2',5'-oligo(A) synthetase activity which was proportional to the concentration of IFN in the medium up to 10(4) U of IFN per ml and then leveled off at about 15 X control activity. Under the assay conditions used, 2',5'-oligo(A) synthetase activity was directly proportional to the amount of cell extract over a 10-fold range. Cattle inoculated with IBR/BVD/PI-3 modified live virus vaccine showed an increase in 2',5'-oligo(A) synthetase activity in peripheral blood mononuclear leukocytes which persisted for at least 3 days postvaccination. Intramuscular injection of cattle with IFN caused a similar increase in 2',5'-oligo(A) synthetase activity. Changes in 2',5'-oligo(A) synthetase activity should be of value in (i) assessing the response of cattle to experimental viral infections or inoculations with viral vaccines or IFN or (ii) indicating a possible viral etiology in disease.

Full text

PDF
1735

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baron S., Dianzani F. General considerations of the interferon system. Tex Rep Biol Med. 1977;35:1–10. [PubMed] [Google Scholar]
  2. Brewster F. E., Byron K. S., Sullivan J. L. Immunoregulation during acute infection with Epstein-Barr virus: dynamics of interferon and 2',5'-oligoadenylate synthetase activity. J Infect Dis. 1985 Jun;151(6):1109–1115. doi: 10.1093/infdis/151.6.1109. [DOI] [PubMed] [Google Scholar]
  3. Buffet-Janvresse C., Hovanessian A. G. Enzyme markers for the presence of circulating interferon: 2-5A synthetase in blood lymphocytes and protein kinase in platelet-rich plasma. Proc Soc Exp Biol Med. 1984 Feb;175(2):169–175. doi: 10.3181/00379727-175-41783. [DOI] [PubMed] [Google Scholar]
  4. Cashel M., Lazzarini R. A., Kalbacher B. An improved method for thin-layer chromatography of nucleotide mixtures containing 32P-labelled orthophosphate. J Chromatogr. 1969 Mar 11;40(1):103–109. doi: 10.1016/s0021-9673(01)96624-5. [DOI] [PubMed] [Google Scholar]
  5. Chousterman S., Chousterman M., Reinert P., Thang M. N. Clinical value of the determination of an interferon-induced enzyme activity: studies of the 2'5' oligoadenylate synthetase activity in peripheral blood lymphocytes of patients. Biomed Pharmacother. 1983;37(4):176–180. [PubMed] [Google Scholar]
  6. Clemens M. J., Williams B. R. Inhibition of cell-free protein synthesis by pppA2'p5'A2'p5'A: a novel oligonucleotide synthesized by interferon-treated L cell extracts. Cell. 1978 Mar;13(3):565–572. doi: 10.1016/0092-8674(78)90329-x. [DOI] [PubMed] [Google Scholar]
  7. Edy V. G., Billiau A., De Somer P. Non-appearance of injected fibroblast interferon in circulation. Lancet. 1978 Feb 25;1(8061):451–452. doi: 10.1016/s0140-6736(78)91251-5. [DOI] [PubMed] [Google Scholar]
  8. Farrell P. J., Sen G. C., Dubois M. F., Ratner L., Slattery E., Lengyel P. Interferon action: two distinct pathways for inhibition of protein synthesis by double-stranded RNA. Proc Natl Acad Sci U S A. 1978 Dec;75(12):5893–5897. doi: 10.1073/pnas.75.12.5893. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Federico M., Romeo G., Affabris E., Coccia E. M., Rossi G. B. 2',5'-Oligoadenylate synthetase-uninducible alpha/beta-interferon-resistant Friend cells develop an antiviral state when permeabilized with lysolecithin and treated with 2',5'-oligoadenylate oligomers. J Interferon Res. 1986 Jun;6(3):233–240. doi: 10.1089/jir.1986.6.233. [DOI] [PubMed] [Google Scholar]
  10. Fujii N., Kotake S., Hirose S., Ohno S., Yasuda I., Sagawa A., Ishikawa K., Minagawa T. Oligo-2',5'-adenylate synthetase activity in peripheral blood mononuclear leukocytes in various diseases. J Clin Microbiol. 1984 Dec;20(6):1216–1218. doi: 10.1128/jcm.20.6.1216-1218.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gresser I., Vignaux F., Belardelli F., Tovey M. G., Maunoury M. T. Injection of mice with antibody to mouse interferon alpha/beta decreases the level of 2'-5' oligoadenylate synthetase in peritoneal macrophages. J Virol. 1985 Jan;53(1):221–227. doi: 10.1128/jvi.53.1.221-227.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hovanessian A. G., Brown R. E., Kerr I. M. Synthesis of low molecular weight inhibitor of protein synthesis with enzyme from interferon-treated cells. Nature. 1977 Aug 11;268(5620):537–540. doi: 10.1038/268537a0. [DOI] [PubMed] [Google Scholar]
  13. Justesen J., Ferbus D., Thang M. N. 2'5' oligoadenylate synthetase, an interferon induced enzyme: direct assay methods for the products, 2'5' oligoadenylates and 2'5' co-oligonucleotides. Nucleic Acids Res. 1980 Jul 25;8(14):3073–3085. doi: 10.1093/nar/8.14.3073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kerr I. M., Brown R. E., Hovanessian A. G. Nature of inhibitor of cell-free protein synthesis formed in response to interferon and double-stranded RNA. Nature. 1977 Aug 11;268(5620):540–542. doi: 10.1038/268540a0. [DOI] [PubMed] [Google Scholar]
  15. Kerr I. M., Brown R. E. pppA2'p5'A2'p5'A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells. Proc Natl Acad Sci U S A. 1978 Jan;75(1):256–260. doi: 10.1073/pnas.75.1.256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Krishnan I., Baglioni C. 2'5' oligo(A) polymerase activity in serum of mice infected with EMC virus or treated with interferon. Nature. 1980 Jun 12;285(5765):485–488. doi: 10.1038/285485a0. [DOI] [PubMed] [Google Scholar]
  17. Krust B., Rivière Y., Hovanessian A. G. p67K kinase in different tissues and plasma of control and interferon-treated mice. Virology. 1982 Jul 15;120(1):240–246. doi: 10.1016/0042-6822(82)90022-8. [DOI] [PubMed] [Google Scholar]
  18. Levin S., Hahn T. Evaluation of the human interferon system in viral disease. Clin Exp Immunol. 1981 Dec;46(3):475–483. [PMC free article] [PubMed] [Google Scholar]
  19. Lodemann E., Kornhuber B., Gerein V., von Il'berg C. (2'-5')oligo(A) synthetase as a monitor of interferon action in juvenile laryngeal papillomatosis. J Interferon Res. 1984 Spring;4(2):283–290. doi: 10.1089/jir.1984.4.283. [DOI] [PubMed] [Google Scholar]
  20. Merlin G., Revel M., Wallach D. The interferon-induced enzyme oligo-isoadenylate synthetase: rapid determination of its in vitro products. Anal Biochem. 1981 Jan 1;110(1):190–196. doi: 10.1016/0003-2697(81)90134-2. [DOI] [PubMed] [Google Scholar]
  21. Merritt J. A., Ball L. A., Sielaff K. M., Meltzer D. M., Borden E. C. Modulation of 2',5'-oligoadenylate synthetase in patients treated with alpha-interferon: effects of dose, schedule, and route of administration. J Interferon Res. 1986 Jun;6(3):189–198. doi: 10.1089/jir.1986.6.189. [DOI] [PubMed] [Google Scholar]
  22. Merritt J. A., Borden E. C., Ball L. A. Measurement of 2',5'-oligoadenylate synthetase in patients receiving interferon-alpha. J Interferon Res. 1985 Winter;5(1):191–198. doi: 10.1089/jir.1985.5.191. [DOI] [PubMed] [Google Scholar]
  23. Minks M. A., Benvin S., Maroney P. A., Baglioni C. Synthesis of 2'5'-oligo(A) in extracts of interferon-treated HeLa cells. J Biol Chem. 1979 Jun 25;254(12):5058–5064. [PubMed] [Google Scholar]
  24. Minks M. A., West D. K., Benvin S., Baglioni C. Structural requirements of double-stranded RNA for the activation of 2',5'-oligo(A) polymerase and protein kinase of interferon-treated HeLa cells. J Biol Chem. 1979 Oct 25;254(20):10180–10183. [PubMed] [Google Scholar]
  25. Penn L. J., Williams B. R. Interferon-induced 2-5A synthetase activity in human peripheral blood mononuclear cells after immunization with influenza virus and rubella virus vaccines. J Virol. 1984 Mar;49(3):748–753. doi: 10.1128/jvi.49.3.748-753.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Preble O. T., Rothko K., Klippel J. H., Friedman R. M., Johnston M. I. Interferon-induced 2'-5' adenylate synthetase in vivo and interferon production in vitro by lymphocytes from systemic lupus erythematosus patients with and without circulating interferon. J Exp Med. 1983 Jun 1;157(6):2140–2146. doi: 10.1084/jem.157.6.2140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Ratner L., Wiegand R. C., Farrell P. J., Sen G. C., Cabrer B., Lengyel P. Interferon, double-stranded RNA and RNA degradation. Fractionation of the endonucleaseINT system into two macromolecular components; role of a small molecule in nuclease activation. Biochem Biophys Res Commun. 1978 Apr 14;81(3):947–954. doi: 10.1016/0006-291x(78)91443-2. [DOI] [PubMed] [Google Scholar]
  28. Roberts W. K., Hovanessian A., Brown R. E., Clemens M. J., Kerr I. M. Interferon-mediated protein kinase and low-molecular-weight inhibitor of protein synthesis. Nature. 1976 Dec 2;264(5585):477–480. doi: 10.1038/264477a0. [DOI] [PubMed] [Google Scholar]
  29. Rose J. K. Heterogneeous 5'-terminal structures occur on vesicular stomatitis virus mRNAs. J Biol Chem. 1975 Oct 25;250(20):8098–8104. [PubMed] [Google Scholar]
  30. Saron M. F., Riviere Y., Hovanessian A. G., Guillon J. C. Chronic production of interferon in carrier mice congenitally infected with lymphocytic choriomeningitis virus. Virology. 1982 Feb;117(1):253–256. doi: 10.1016/0042-6822(82)90524-4. [DOI] [PubMed] [Google Scholar]
  31. Schattner A., Merlin G., Shapira A., Revel M., Wallach D. Comparison of (2'-5') oligo-adenylate synthetase and interferon blood-levels in mice early after viral infection. J Interferon Res. 1982;2(2):285–289. doi: 10.1089/jir.1982.2.285. [DOI] [PubMed] [Google Scholar]
  32. Schattner A., Wallach D., Merlin G., Hahn T., Levin S., Revel M. Assay of an interferon-induced enzyme in white blood cells as a diagnostic aid in viral diseases. Lancet. 1981 Sep 5;2(8245):497–500. doi: 10.1016/s0140-6736(81)90883-7. [DOI] [PubMed] [Google Scholar]
  33. Sugino H., Mitani I., Koike M., Kodama T., Sokawa J., Sawai H., Ishibashi K., Itoh M., Watanabe S., Sokawa Y. Detection of elevated levels of 2-5A synthetase in serum from children with various infectious diseases. J Clin Microbiol. 1986 Sep;24(3):478–481. doi: 10.1128/jcm.24.3.478-481.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Vanden Broecke C., Plasman P. O., Pirak M., Thiry E., Schwers A., Piscitelli S., Ligongo G., Pastoret P. P., Werenne J. Human recombinant interferon in the bovine species: induction of 2'5'A synthetase and antiviral activity. Prog Clin Biol Res. 1985;202:333–338. [PubMed] [Google Scholar]
  35. Vilcek J., Kohase M. Regulation of interferon production: cell culture studies. Tex Rep Biol Med. 1977;35:57–62. [PubMed] [Google Scholar]
  36. Zilberstein A., Kimchi A., Schmidt A., Revel M. Isolation of two interferon-induced translational inhibitors: a protein kinase and an oligo-isoadenylate synthetase. Proc Natl Acad Sci U S A. 1978 Oct;75(10):4734–4738. doi: 10.1073/pnas.75.10.4734. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES